Steve Burke

1.5k total citations
15 papers, 832 citations indexed

About

Steve Burke is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Steve Burke has authored 15 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Steve Burke's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Steve Burke is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Steve Burke collaborates with scholars based in United States, Spain and Denmark. Steve Burke's co-authors include Ezio Bonvini, Syd Johnson, Sergey Gorlatov, Scott Koenig, Hua Li, Ling Huang, Paul A. Moore, Valentina Ciccarone, Jeffrey B. Stavenhagen and Yinhua Yang and has published in prestigious journals such as Blood, The Journal of Immunology and The Journal of Physiology.

In The Last Decade

Steve Burke

14 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Burke United States 9 493 437 352 281 77 15 832
Fabrice Le Gall Germany 16 650 1.3× 356 0.8× 356 1.0× 495 1.8× 40 0.5× 20 998
Bernhard Stockmeyer Germany 23 797 1.6× 590 1.4× 964 2.7× 465 1.7× 96 1.2× 35 1.4k
Gerd Ritter United States 13 443 0.9× 269 0.6× 302 0.9× 429 1.5× 50 0.6× 15 948
Alexander V. Taranin Russia 17 280 0.6× 232 0.5× 608 1.7× 238 0.8× 60 0.8× 73 910
Irene Ni United States 11 379 0.8× 166 0.4× 356 1.0× 347 1.2× 39 0.5× 15 743
N M Avdalovic United States 9 585 1.2× 212 0.5× 361 1.0× 472 1.7× 53 0.7× 9 1.0k
Glenn Pilkington Australia 9 206 0.4× 288 0.7× 394 1.1× 185 0.7× 45 0.6× 15 690
Jonathan Stevens United States 8 177 0.4× 455 1.0× 650 1.8× 536 1.9× 22 0.3× 13 1.0k
Liang‐Ji Zhou United States 9 146 0.3× 205 0.5× 781 2.2× 320 1.1× 69 0.9× 10 1.1k
Juha Hakulinen Finland 15 164 0.3× 161 0.4× 522 1.5× 432 1.5× 44 0.6× 17 1.0k

Countries citing papers authored by Steve Burke

Since Specialization
Citations

This map shows the geographic impact of Steve Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Burke more than expected).

Fields of papers citing papers by Steve Burke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Burke. The network helps show where Steve Burke may publish in the future.

Co-authorship network of co-authors of Steve Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Burke. A scholar is included among the top collaborators of Steve Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Burke. Steve Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Burke, Steve, et al.. (2024). Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy. Journal of Translational Medicine. 22(1). 664–664. 1 indexed citations
2.
Burke, Steve, et al.. (2023). Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles. The Journal of Physiology. 601(5). 961–978. 6 indexed citations
3.
Wang, Xueyong, Christopher L. Dupont, Steve Burke, et al.. (2022). The role of action potential changes in depolarization-induced failure of excitation contraction coupling in mouse skeletal muscle. eLife. 11. 12 indexed citations
4.
Liu, Liqin, Chia‐Ying K. Lam, Yinhua Yang, et al.. (2016). MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clinical Cancer Research. 23(6). 1506–1518. 59 indexed citations
5.
Phillips, John R., et al.. (2016). Protecting Puget Sound from CSOs by retrofitting Urban Neighborhoods with Green Stormwater Infrastructure. Western CEDAR (Western Washington University).
6.
Chichili, Gurunadh R., Ling Huang, Hua Li, et al.. (2015). A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates. Science Translational Medicine. 7(289). 289ra82–289ra82. 117 indexed citations
7.
Moore, Paul A., Ralph Alderson, Kalpana Shah, et al.. (2014). Abstract 669: Development of MGD007, a gpA33 x CD3 bi-specific DART for T-cell immunotherapy of metastatic colorectal cancer. Cancer Research. 74(19_Supplement). 669–669. 6 indexed citations
8.
9.
Chen, Wei, Steve Burke, Valentina Ciccarone, et al.. (2014). Development of human B-lymphocyte targeted bi-specific DART® molecules for the treatment of autoimmune disorders (THER5P.830). The Journal of Immunology. 192(Supplement_1). 200.9–200.9. 5 indexed citations
10.
Nordstrom, Jeffrey L., Sergey Gorlatov, Wenjun Zhang, et al.. (2011). Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties. Breast Cancer Research. 13(6). R123–R123. 183 indexed citations
11.
Moore, Paul A., Wenjun Zhang, G. Jonah Rainey, et al.. (2011). Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma. Blood. 117(17). 4542–4551. 209 indexed citations
12.
Moore, Paul A., Wenjun Zhang, Steve Burke, et al.. (2010). Abstract 5629: Application of a novel bispecific antibody-based scaffold for optimal redirected T-cell killing of cancer cells. Cancer Research. 70(8_Supplement). 5629–5629. 1 indexed citations
13.
14.
Rankin, Christopher T., Maria-Concetta Verı́, Sergey Gorlatov, et al.. (2006). CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. Blood. 108(7). 2384–2391. 70 indexed citations
15.
Burke, Steve, Andrew S. Pullin, Robert J. Wilson, & Chris D. Thomas. (2005). Selection for discontinuous life‐history traits along a continuous thermal gradient in the butterfly Aricia agestis. Ecological Entomology. 30(6). 613–619. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabrice Le Gall Breakdown of academic impact, for papers by Bernhard Stockmeyer Breakdown of academic impact, for papers by Gerd Ritter Breakdown of academic impact, for papers by Alexander V. Taranin Breakdown of academic impact, for papers by Irene Ni Breakdown of academic impact, for papers by N M Avdalovic Breakdown of academic impact, for papers by Glenn Pilkington Breakdown of academic impact, for papers by Jonathan Stevens Breakdown of academic impact, for papers by Liang‐Ji Zhou Breakdown of academic impact, for papers by Juha Hakulinen
Rankless by CCL
2026